Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi’s Increased Bid For Zentiva Brings Expansion Closer

This article was originally published in The Tan Sheet

Executive Summary

Sanofi-Aventis' expansion plans move closer to fruition with an increased offer for Zentiva, which sells OTC drugs and dietary supplements as well as Rx products in emerging markets in Central and Eastern Europe
Advertisement

Related Content

Sanofi gets go-ahead for Zentiva buy
Sanofi gets go-ahead for Zentiva buy
Sanofi gets go-ahead for Zentiva buy
Merck KGaA Consumer Business Could Flourish In The Right Hands – Analysts
Merck KGaA Consumer Business Could Flourish In The Right Hands – Analysts
Sales & Earnings In Brief
People In Brief
Sanofi-Aventis Nurtures Supplement Interest With Symbion Consumer Buy
Sanofi-Aventis Nurtures Supplement Interest With Symbion Consumer Buy
Under New CEO, Glaxo Will Leverage OTCs In Emerging Markets

Topics

Advertisement
UsernamePublicRestriction

Register

PS102155

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel